Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 550 of 3546 entries
View as:

A Study Comparing 4 Doses Of GW810781 Versus Placebo In HIV-Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT00046332 Org: User:
Start: 06/30/02 End: 01/31/03 Due: 01/31/04

A 5-way Treatment Period Trial of Single Doses of Intranasal GSK256066 in Patients With Rhinitis

Phase: N/A Priority: Normal
NCT ID: NCT00464568 Org: User:
Start: 03/28/07 End: 05/16/07 Due: 05/16/08

Special Drug Use Investigation for PAXIL (Paroxetine) Social Anxiety Disorder (Long-term)

Phase: N/A Priority: Normal
NCT ID: NCT01376271 Org: User:
Start: 01/31/10 End: 09/30/13 Due: 09/30/14

GW572016, An Oral Drug For Colorectal Cancer Patients Having Prior Therapy With 5-FU Plus CPT-11 And/Or Oxaliplatin

Phase: N/A Priority: Normal
NCT ID: NCT00044343 Org: User:
Start: 09/30/02 End: 10/31/03 Due: 10/31/04

Ofatumumab Dose-finding in Relapsing Remitting Multiple Sclerosis (RRMS) Patients

Phase: N/A Priority: Normal
NCT ID: NCT00640328 Org: User:
Start: 05/31/08 End: 10/31/11 Due: 10/31/12

To Study And Compare Bioavailability And Safety Of Four Different Formulations Of The Study Drug

Phase: N/A Priority: Normal
NCT ID: NCT00436228 Org: User:
Start: 11/30/06 End: 02/28/07 Due: 02/28/08

Study to Determine the Effect of Itraconazole on the Pharmacokinetics of Rilapladib (SB659032) in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02130661 Org: User:
Start: 10/31/17 End: 01/31/18 Due: 01/31/19

The Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity (DH)

Phase: N/A Priority: Normal
NCT ID: NCT02924350 Org: User:
Start: 11/07/16 End: 03/17/17 Due: 03/17/18

Viapaed Study In Children And Adolescents With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00315744 Org: User:
Start: 11/04/04 End: 04/12/07 Due: 04/12/08

An Epidemiological Surveillance Study to Evaluate the Incidence of Dengue in Brazil

Phase: N/A Priority: Normal
NCT ID: NCT01751139 Org: User:
Start: 02/18/14 End: 12/20/18 Due: 12/20/19

A Protocol to Collect Human Serum Samples From Healthy Adults for Use as Quality Controls Samples in GlaxoSmithKline (GSK) Biologicals' Assays

Phase: N/A Priority: Normal
NCT ID: NCT02072525 Org: User:
Start: 04/01/14 End: 06/02/15 Due: 06/02/16

Special Drug Use Investigation for ALLERMIST (Long Term)

Phase: N/A Priority: Normal
NCT ID: NCT01420822 Org: User:
Start: 12/31/10 End: 08/31/14 Due: 08/31/15

Efficacy and Safety Study of Eltrombopag in Pediatric Patients With Thrombocytopenia From Chronic Idiopathic Thrombocytopenic Purpura (ITP)

Phase: N/A Priority: Normal
NCT ID: NCT00908037 Org: User:
Start: 09/30/09 End: 02/01/14 Due: 02/01/15

Evaluation of Boostrix™10 Years After Previous Booster Vaccination

Phase: N/A Priority: Normal
NCT ID: NCT01147900 Org: User:
Start: 06/15/10 End: 05/08/12 Due: 05/08/13

A Study to Determine the Bioavailability of a Fixed Dose Combination Product of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) Relative to Co-administration of the Individual Components in Healthy Male Subjects of North East Asian and Non-Asian Ancestry.

Phase: N/A Priority: Normal
NCT ID: NCT01254071 Org: User:
Start: 09/10/10 End: 12/21/10 Due: 12/21/11

Milk-only Lactation Study for Patients on Eltrombopag

Phase: N/A Priority: Normal
NCT ID: NCT01055600 Org: User:
Start: 03/31/13 End: 07/31/14 Due: 07/31/15

A Study of Patient Management in HIV-1 Infected Patients Found to Have the Genetic Marker HLA-B*5701

Phase: N/A Priority: Normal
NCT ID: NCT00435838 Org: User:
Start: 03/31/07 End: - Due: -

A Study to Evaluate the Effect of Repeat Doses of GW870086X in Mild to Moderate Asthmatics

Phase: N/A Priority: Normal
NCT ID: NCT00945932 Org: User:
Start: 07/31/09 End: 12/31/09 Due: 12/31/10

Extension Study of GI198745 to Treat Benign Prostatic Hyperplasia

Phase: N/A Priority: Normal
NCT ID: NCT00969072 Org: User:
Start: 08/31/03 End: 02/28/05 Due: 02/28/06

Dose Response and Efficacy of GW842166 in Pain

Phase: N/A Priority: Normal
NCT ID: NCT00554762 Org: User:
Start: 11/30/07 End: 03/31/08 Due: 03/31/09

An Observational, Epidemiological Study on the Prevalence of Human Papillomavirus Types in Women in Egypt

Phase: N/A Priority: Normal
NCT ID: NCT01158209 Org: User:
Start: 10/31/10 End: 08/31/11 Due: 08/31/12

An Efficacy Study of GSK2269557 Added to Standard Care in Subjects With an Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT02294734 Org: User:
Start: 03/31/15 End: 04/25/16 Due: 04/25/17

Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants

Phase: N/A Priority: Normal
NCT ID: NCT02096263 Org: User:
Start: 04/16/14 End: 11/13/15 Due: 11/13/16

PET (Positron Emission Tomography)/Public Speaking Study With A Combination Of 2 Medications In Social Anxiety Patients

Phase: N/A Priority: Normal
NCT ID: NCT00343707 Org: User:
Start: 11/30/04 End: 11/30/05 Due: 11/30/06

Evaluation Of Missed Osteoporosis Diagnoses, And Preference Between Once Monthly Ibandronate And Once Weekly Alendronate

Phase: N/A Priority: Normal
NCT ID: NCT00327990 Org: User:
Start: 04/30/05 End: 12/31/06 Due: 12/31/07